Shojiro Kyotani

840 total citations
34 papers, 676 citations indexed

About

Shojiro Kyotani is a scholar working on Pharmacology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Shojiro Kyotani has authored 34 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 7 papers in Molecular Biology. Recurrent topics in Shojiro Kyotani's work include Pharmacological Effects of Natural Compounds (8 papers), Epilepsy research and treatment (5 papers) and Phytochemistry and Biological Activities (4 papers). Shojiro Kyotani is often cited by papers focused on Pharmacological Effects of Natural Compounds (8 papers), Epilepsy research and treatment (5 papers) and Phytochemistry and Biological Activities (4 papers). Shojiro Kyotani collaborates with scholars based in Japan and China. Shojiro Kyotani's co-authors include Yutaka Nishioka, Mitsuhiko Miyamura, Junko Yokota, Saburo Yoshioka, Masahiko Kusunose, Atsuhide Hamada, Toshiaki Hashimoto, Masahito Morimoto, Tailin Cui and Toshiji Saibara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Pharmacy and Pharmacology.

In The Last Decade

Shojiro Kyotani

34 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shojiro Kyotani Japan	16	176	152	121	93	72	34	676
Saburo Yoshioka Japan	15	253 1.4×	128 0.8×	129 1.1×	82 0.9×	88 1.2×	39	694
Nari Yun South Korea	9	225 1.3×	138 0.9×	103 0.9×	93 1.0×	68 0.9×	13	606
Enayat A. Omara Egypt	19	220 1.3×	181 1.2×	194 1.6×	75 0.8×	63 0.9×	77	1.0k
Marilene Porawski Brazil	16	202 1.1×	81 0.5×	88 0.7×	105 1.1×	76 1.1×	38	798
Jung-Hyo Cho South Korea	16	177 1.0×	257 1.7×	99 0.8×	86 0.9×	22 0.3×	88	865
Nancy Vargas-Mendoza Mexico	12	207 1.2×	277 1.8×	144 1.2×	63 0.7×	82 1.1×	21	812
Yue Zhu China	18	314 1.8×	86 0.6×	127 1.0×	46 0.5×	50 0.7×	29	822
Özlem Gök Türkiye	13	168 1.0×	57 0.4×	74 0.6×	132 1.4×	55 0.8×	43	613
Yi‐Ling Lin Taiwan	16	281 1.6×	90 0.6×	57 0.5×	103 1.1×	73 1.0×	35	831
Mi-Rae Shin South Korea	14	207 1.2×	106 0.7×	98 0.8×	60 0.6×	58 0.8×	77	710

Countries citing papers authored by Shojiro Kyotani

Since Specialization

Citations

This map shows the geographic impact of Shojiro Kyotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shojiro Kyotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shojiro Kyotani more than expected).

Fields of papers citing papers by Shojiro Kyotani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shojiro Kyotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shojiro Kyotani. The network helps show where Shojiro Kyotani may publish in the future.

Co-authorship network of co-authors of Shojiro Kyotani

This figure shows the co-authorship network connecting the top 25 collaborators of Shojiro Kyotani. A scholar is included among the top collaborators of Shojiro Kyotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shojiro Kyotani. Shojiro Kyotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morimoto, Masahito, et al.. (2020). Assessment of oxidative stress in autism spectrum disorder using reactive oxygen metabolites and biological antioxidant potential. PLoS ONE. 15(5). e0233550–e0233550. 23 indexed citations

Morimoto, Masahito, et al.. (2020). Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder. Journal of Pharmaceutical Health Care and Sciences. 6(1). 8–8. 14 indexed citations

Morimoto, Masahito, et al.. (2019). Evaluation of oxidative stress and antioxidant capacity in healthy children. Journal of the Chinese Medical Association. 82(8). 651–654. 24 indexed citations

Yokota, Junko, Shiro Ishida, Atsuhide Hamada, & Shojiro Kyotani. (2018). Effect of Particle Size of Nonsteroidal Anti-Inflammatory Drug on Lipopolysaccharide-Induced Inflammation on RAW264.7 Cells. International Journal of Drug Development and Research. 10(3). 1 indexed citations

Yokota, Junko & Shojiro Kyotani. (2018). Influence of nanoparticle size on the skin penetration, skin retention and anti-inflammatory activity of non-steroidal anti-inflammatory drugs. Journal of the Chinese Medical Association. 81(6). 511–519. 51 indexed citations

Morimoto, Masahito, et al.. (2017). Impact of Oxidative Stress and Newer Antiepileptic Drugs on the Albumin and Cortisol Value in Severe Motor and Intellectual Disabilities With Epilepsy. Journal of Clinical Medicine Research. 10(2). 137–145. 16 indexed citations

Yokota, Junko, Kohei Jobu, Atsuhide Hamada, et al.. (2010). Eriobotrya japonica seed extract and deep sea water protect against indomethacin-induced gastric mucosal injury in rats. Journal of Natural Medicines. 65(1). 9–17. 6 indexed citations

Yoshioka, Saburo, et al.. (2010). Immunomodulatory Effect of Eriobotrya japonica Seed Extract on Allergic Dermatitis Rats. Journal of Nutritional Science and Vitaminology. 56(2). 145–149. 10 indexed citations

Muramoto, Kazuyo, Shojiro Kyotani, Mitsuhiko Miyamura, et al.. (2010). Ameliorative effects of Eriobotrya japonica seed extract on cellular aging in cultured rat fibroblasts. Journal of Natural Medicines. 65(2). 254–261. 4 indexed citations

10.

Hamada, Atsuhide, Junko Yokota, Saburo Yoshioka, et al.. (2009). Animal studies supporting the inhibition of mast cell activation byEriobotrya japonicaseed extract. Journal of Pharmacy and Pharmacology. 61(2). 237–241. 6 indexed citations

11.

Hamada, Atsuhide, Junko Yokota, Saburo Yoshioka, et al.. (2009). Animal studies supporting the inhibition of mast cell activation by <I>Eriobotrya japonica</I> seed extract. Journal of Pharmacy and Pharmacology. 61(2). 237–241. 4 indexed citations

12.

Yokota, Junko, Atsuhide Hamada, Saburo Yoshioka, et al.. (2007). Gastroprotective activity of Eriobotrya japonica seed extract on experimentally induced gastric lesions in rats. Journal of Natural Medicines. 62(1). 96–100. 9 indexed citations

13.

Yokota, Junko, Atsuhide Hamada, Saburo Yoshioka, et al.. (2006). Scavenging of Reactive Oxygen Species by Eriobotrya japonica Seed Extract. Biological and Pharmaceutical Bulletin. 29(3). 467–471. 60 indexed citations

14.

Yokota, Junko, Atsuhide Hamada, Saburo Yoshioka, et al.. (2005). Effects of Eriobotrya japonica Seed Extract in a Model Rat of Lipopolysaccharide-induced Inflammation. Nippon Shokuhin Kagaku Kogaku Kaishi. 52(2). 88–93. 3 indexed citations

15.

Hamada, Atsuhide, Saburo Yoshioka, Junko Yokota, et al.. (2004). The Effect of Eriobotrya japonica Seed Extract on Oxidative Stress in Adriamycin-Induced Nephropathy in Rats. Biological and Pharmaceutical Bulletin. 27(12). 1961–1964. 47 indexed citations

16.

Kusunose, Masahiko, Tailin Cui, Atsuhide Hamada, et al.. (2002). Effect of Sho-saiko-to Extract on Hepatic Inflammation and Fibrosis in Dimethylnitrosamine Induced Liver Injury Rats.. Biological and Pharmaceutical Bulletin. 25(11). 1417–1421. 55 indexed citations

17.

Yoshioka, Saburo, et al.. (2001). Survey on Outpatients' Views for One-Dose Package in Kochi Medical School Hospital and Influence of One-Dose Package on Dispensing Error.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 27(4). 356–362. 6 indexed citations

18.

Nishioka, Yutaka, et al.. (1999). Stability of Tablets and Capsules on One-Dose Package.. Japanese Journal of Hospital Pharmacy. 25(4). 385–392. 1 indexed citations

19.

Nishioka, Yutaka, et al.. (1996). A Study on Ethical Kampo Formulation Medicines. Contents of Acffve Ingredients of Ethical Kakkon-to and Sho-seiryu-to Extract Preparations.. Japanese Journal of Hospital Pharmacy. 22(5). 473–481. 1 indexed citations

20.

Nakamura, Takeo, et al.. (1992). In Vitro Studies on the Evaluation of Clay Minerals as Paraquat Adsorbent.. 36(6). 345–350. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact